This inventor holds 1 USPTO granted patent. Top assignee: University-Industry Cooperation Group of Kyung Hee University. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Hyeonkyeong Chae: Innovator in Neuropathic Pain Treatment
Introduction: Hyeonkyeong Chae is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of neuropathic pain. His innovative approach focuses on utilizing natural compounds to address complex health issues.
Latest Patents: Hyeonkyeong Chae holds 1 patent for his invention titled "Composition for preventing or treating neuropathic pain, containing syringaresinol." This composition is designed to prevent, ameliorate, or treat neuropathic pain by incorporating syringaresinol or a pharmaceutically acceptable salt as an active ingredient. The invention is particularly beneficial for subjects scheduled to receive anticancer agents or those who have experienced peripheral nerve damage.
Career Highlights: Hyeonkyeong Chae is affiliated with the University-Industry Cooperation Group of Kyung Hee University. His work in this group emphasizes collaboration between academic research and industry applications, aiming to translate scientific discoveries into practical solutions for healthcare challenges.
Collaborations: Hyeonkyeong Chae has worked alongside esteemed colleagues such as Zee Hwan Lee and Jonghee Choi. Their collaborative efforts contribute to advancing research and innovation in the medical field.
Conclusion: Hyeonkyeong Chae's contributions to neuropathic pain treatment highlight the importance of innovative research in medicine. His work exemplifies the potential of natural compounds in developing effective therapeutic solutions.